HomeInsightsMarket Capitalization

Market Capitalization of Vanta Bioscience Ltd

Market Capitalization of Vanta Bioscience Ltd

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 4, 2024)

stocks purchased

0.8 K

Stocks Traded

(Dec 4, 2024)

Last Updated on: Dec 04, 2024

Image

Vanta Bioscience Ltd

NSE: VANTABIOSCIENCE

Market Cap

₹ 30.18 crore

Last updated on: Dec 04, 2024

Key Highlights

  • The Market Cap of Vanta Bioscience Ltd is ₹ 30.18 crore as of 04 Dec 24 .
  • The Market Cap of Vanta Bioscience Ltd changed from ₹ 96.54 crore on March 2019 to ₹ 40.4 crore on March 2024 . This represents a CAGR of -13.51% over 6 years.
  • The Latest Trading Price of Vanta Bioscience Ltd is ₹ 47.82 as of 04 Dec 15:30 .

Historical Market Cap of Vanta Bioscience Ltd

No data available

* All values are in crore

Company Fundamentals for Vanta Bioscience Ltd

No data available

Image

Vanta Bioscience Ltd

NSE: VANTABIOSCIENCE

Share Price

₹ 47.82

-2.51 (-4.99%)

stock direction

Last updated on: Dec 04, 2024

Market Price of Vanta Bioscience Ltd

1M

1Y

3Y

5Y

Monitoring Vanta Bioscience Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Dec 202447.82
28 Nov 202450.33
27 Nov 202448.98
26 Nov 202447.32
25 Nov 202445.16
22 Nov 202443.07
19 Nov 202441.07
18 Nov 202439.13
14 Nov 202441.18
12 Nov 202443.34

BlinkX Score for Vanta Bioscience Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Vanta Bioscience Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Vanta Bioscience Ltd

No data available

No data available

Historical P/E Ratio of Vanta Bioscience Ltd

No data available

* All values are in %

Historical Revenue of Vanta Bioscience Ltd

No data available

* All values are in crore

Historical EBITDA of Vanta Bioscience Ltd

No data available

* All values are in crore

Historical Net Profit of Vanta Bioscience Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Vanta Bioscience Ltd

  • Vanta Bioscience Limited was originally incorporated as a Private Limited Company on 29th April 2016 with the name 'Vanta Bioscience Private Limited'.
  • The Company converted into a Public Limited Company and the name was changed to 'Vanta Bioscience Limited' on 17th March 2017. The Company is presently engaged in the business of Preclinical Activities.
  • The Company provides risk assessment services for evaluating safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of product. The Company is established as a center of excellence for GLP toxicology and safety assessment offering services in India and across the globe.
  • One of the major services of VBS is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world.

Vanta Bioscience Ltd News Hub

News

Vanta Bioscience to hold board meeting

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 6 Decembe...

Read more

04 Dec 2024 11:01

News

Vanta Bioscience to declare Quarterly Result

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 14 Novemb...

Read more

12 Nov 2024 11:26

News

Vanta Bioscience postpones board meeting

Vanta Bioscience has postponed the meeting of the Board of Directors which was scheduled t...

Read more

18 Jul 2024 10:17

News

Vanta Bioscience to table results

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 17 July 2...

Read more

11 Jul 2024 09:47

News

Vanta Bioscience wins order of Rs 1.2 cr

Vanta Bioscience has received an order of Rs. 1.2 crore from a large Indian Multinational ...

Read more

03 Apr 2024 15:22

News

Vanta Bioscience wins order of Rs 57 lakh

Vanta Bioscience has received order of Rs 57 lakh from a renowned Singapore Company to car...

Read more

02 Dec 2023 11:47

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Vanta Bioscience Ltd Market Cap

What is the market cap of Vanta Bioscience Ltd?

As of December 4, 2024, Vanta Bioscience Ltd has a market capitalization of ₹30.18, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Vanta Bioscience Ltd's market capitalization?

Vanta Bioscience Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Vanta Bioscience Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Vanta Bioscience Ltd's market capitalization change?

Vanta Bioscience Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions